Ending parasitic diseases through vaccine innovation.
OptoVAX is at the forefront of biotechnology research, dedicated to developing innovative solutions for vaccine production. With a novel platform technology focused on live attenuated vaccines, OptoVAX is committed to ending parasitic diseases through pioneering research and development. The company's headquarters are located in Berlin, DE.
OptoVAX specializes in vaccines, immunology, and infectious diseases, striving to make significant contributions to global health. Supported by the GoBio initial program and the German Federal Institute for Education and Research (BMBF), along with Profund Innovation Freie Universität Berlin, OptoVAX is positioned to achieve remarkable advancements in the field.
OptoVAX is poised for continued growth and success in the biotechnology sector. For more detailed information about OptoVAX and its groundbreaking work, please visit www.optovax.com. We invite the management team at OptoVAX to create a customized and exclusive company showcase and product listing on our platform.
Compare OptoVAX with 3 companies in Biotechnology-Research
| Comparison Field |
OptoVAXMain Company |
Bavarian NordicView Profile |
MSD in the UKView Profile |
TSTrialsView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1994 | 1891 | 2016 |
|
Company Size
|
— | 1,001-5,000 | 1,001-5,000 | 1,001-5,000 |
|
City
|
Copenhagen, Capital Region | |||
|
Country
|
Denmark | |||
|
Skills & Keywords
Comparing with main company
|
7 Total Skills
Vaccines
Immunology
Infectious Diseases
Biotechnology
Pharmaceuticals
Vaccine Development
Global Health
|
2 Total
2 Unique
Unique Skills:
Biodefense
Vaccine Manufacturing
|
5 Total
5 Unique
Unique Skills:
Cardiovascular Diseases
Diabetes
HIV
Inventing for Life
Oncology
|
8 Total
8 Unique
Unique Skills:
Clinical Trials
Infectious Disease
Metabolic Disorders
Oncology
Rare Disease
Respiratory Disease
+2
|
Other organizations in the same industry
This company is also known as